Credit: Karin Tilch There are no therapeutics available that have been developed for COVID-19 treatment. Repurposing of already available medication for COVID-19 therapy is an attractive...
Preclinical study outcomes are more likely to predict clinical study outcomes if new, bet-ter-humanized small animal models are deployed. The post Animal Models Offer Improved Translatability...
New immunotherapy developments include the use of tumor-infiltrating lymphocytes, allogeneic T cells, co-stimulatory signals, and engineered cytokines. The post Reinforcing the Body’s Defenses against Cancer appeared...
In this roundtable discussion, four experts from academia and industry met to discuss challenges in refining and scaling up AAV production pipelines to meet the increasing...
Vir Biotechnology and GlaxoSmithKline said they will pause enrollment into a study testing their experimental Covid-19 antibody therapy
ISA Pharmaceuticals is planning to take its COVID-19 immunotherapy into the clinic, aiming to harness the power of The post ISA plans trials of T-cell boosting...
Another trial of convalescent plasma in people with COVID-19 has missed the mark, this time in mild to The post NIH abandons convalescent plasma trial in...
Shares of KemPharm Inc. exploded 93% in Wednesday’s pre-market trading session after the US Food and Drug Administration (FDA) approved its treatment for attention deficit hyperactivity...
Merck announced on March 1 the voluntary withdrawal of the U.S. indication for Keytruda (pembrolizumab) for the treatment of patients with metastatic small cell lung cancer...
Biocept entered into a supply agreement with Aegea Biotechnologies for a new PCR-based Covid-19 assay kit. Shares of Biocept fell 1.2% in midday US trading.
CryoPort outperformed sales expectations for the fourth quarter amid a rebound in clinical trial activity from the COVID-19 impact. Shares of the temperature-controlled logistics and biostorage...
With outdated delivery systems at many hospitals and clinics, mistakes can lead to costly duplication of services and poor patient outcomes. But there are ways to...
But researchers say tocilizumab, a monoclonal antibody treatment, may reduce ventilator use and shorten hospital stays Credit: Photo courtesy of Roche In a study published online...
There is still no cure for COVID-19, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.
Regeneron Pharmaceuticals released positive Phase 2 trial results, which showed that a single dose of of its investigational antibody cocktail therapy prevented early asthma reactions in cat-allergic...
Penny Stocks Are Risky But These 3 May Be Ones To Watch Right Now The post 3 Penny Stocks Turning Heads Before March But Are They...
Eli Lilly said the U.S. government agreed to buy at least 100,000 doses of the company's newly authorized COVID-19 dual antibody cocktail for $210 million, with...
Pharma’s historic R&D efforts have given us some light at the end of the COVID tunnel. Now it’s The post Deep Dive: Research and Development appeared...
Set up by three brothers back in 1886, Johnson & Johnson continues to keep evolving The post A history of Johnson & Johnson appeared first on...
Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for The post Merck takes on Lilly/Nektar in IL-2...
Otsuka and Click Therapeutics are working with Verily, the healthcare subsidiary of Google owners Alphabet, on a fully The post Otsuka, Click trial digital depression therapy...
These Penny Stocks Are Heating Up As Biotech Sector Surges
The mental health wellness sector is poised to expand as mental health issues continue to disrupt the world. The post Follow the Money: Investments in Mental...
The Canadian pharmaceutical market is the 10th largest in the world. What are the biggest pharma stocks on the TSX and TSXV? The post 5 Biggest Canadian...
Prof. Thomas H. Epps, III named to American Institute for Medical and Biological Engineering College of Fellows Credit: Photo by Kathy F. Atkinson | Illustration by...
Employers today often use perks to attract new talent in the form of discounts and deals, commuter funds, gym memberships, childcare, free lunches and more. But...
As the world has focused on the COVID-19 pandemic, other microbial foes are waging war on humans. Antibiotic-resistant bacteria pose a growing threat. But viruses may...
Inspire Medical Systems' shares were up about 6.4% in Wednesday’s pre-market trading session after the medical technology company's 2021 revenue guidance topped the Street’s estimates. Meanwhile,...
The U.S. Food and Drug Administration accepted for Priority Review Pfizer Inc.’s Biologics License Application for TicoVac, the company's tick-borne encephalitis vaccine for active immunization to...
Credit: NIAID and Colorado State University WHAT: A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle...